Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab2Terminated1
DB18672Suratadenoturev2Terminated1